CytoDyn Launches Feasibility Study in China

SANTA FE, N.M.--(BUSINESS WIRE)--After meeting with representatives of the Xishan Economic Development Zone in Albuquerque, New Mexico, CytoDyn, Inc. (Pink Sheets: CYDY) has committed to a feasibility study in the People’s Republic of China. Dr. Feng Zhou, a Company consultant, will travel to China in the immediate future to confer with workers at the sFDA and selected biotechnology facilities on CytoDyn’s behalf.